Cilostazol reduces microalbuminuria in type 2 diabetic nephropathy

Abstract

Diabetic nephropathy (DN) is the most common microvascular complication of diabetes and is one of the major causes of end-stage renal disease (ESRD).Cilostazol,an antiplatelet drug,plays an important role in the prevention and treatment of the chronic complications of diabetes through a series of mechanisms,including anti-inflammation,the inhibition of vascular smooth muscle proliferation,the protection of nerve cells,and the regulation of blood lipids.